Author:
Linton A,Pavlakis N,O'Connell R,Soeberg M,Kao S,Clarke S,Vardy J,van Zandwijk N
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Abakay A, Komek H, Abakay O, Palanci Y, Ekici F, Tekbas G, Tanrikulu AC (2013) Relationship between 18 FDG PET-CT findings and the survival of 177 patients with malignant pleural mesothelioma. Eur Rev Med Pharmacol Sci 17 (9): 1233–1241.
2. Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, Lederman G, Corson J (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol 6 (1): 147–153.
3. Australian-Bureau-of-Statistics (2011) Australian Statistical Geography Standard (ASGS) Volume 5, Remoteness Areas Commonwealth of Australia: Canberra, Australia.
4. Blum W, Schwaller B (2013) Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy? Int J Cancer 133 (9): 2077–2088.
5. Bolukbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J (2011) Survival after trimodality therapy for malignant pleural mesothelioma: radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy. Lung Cancer 71 (1): 75–81.
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献